---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293357949.md"
description: "PolyPid shares are trading lower. The company announced it has entered into an exclusive commercial partnership agreement with Azurity Pharmaceuticals for the commercialization of D-PLEX100."
datetime: "2026-07-21T14:30:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293357949.md)
  - [en](https://longbridge.com/en/news/293357949.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293357949.md)
generator: "portal-rs"
---

# 

PolyPid shares are trading lower. The company announced it has entered into an exclusive commercial partnership agreement with Azurity Pharmaceuticals for the commercialization of D-PLEX100.

### Related Stocks

- [PYPD.US](https://longbridge.com/en/quote/PYPD.US.md)

## Related News & Research

- [PolyPid Ltd. (NASDAQ:PYPD) Sees Large Drop in Short Interest](https://longbridge.com/en/news/297431820.md)
- [PolyPid (PYPD) Q2 2026 Earnings Call: D-PLEX100 Priority Review and Azurity Deal](https://longbridge.com/en/news/295904620.md)
- [Here's How Much $100 Invested In Parker Hannifin 5 Years Ago Would Be Worth Today](https://longbridge.com/en/news/297380077.md)
- [PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential](https://longbridge.com/en/news/293345524.md)
- [Here's How Much $100 Invested In US Foods Holdings 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296953049.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**